Search Results - Sarbjit S. Saini

Efficacy and safety of CT‐P39, an omalizumab biosimilar, in chronic spontaneous urticaria: 16‐week follow‐up study by Clive Grattan, Yevgeniya Dytyatkovska, Michał Springer, Maria Ratkova, Borislava Krusheva, Izabella Krupa‐Borek, Grazyna Pulka, Marta Chełmińska, Adam Reich, Sunghyun Kim, Yunju Bae, Suyoung Kim, Sewon Lee, Eunjin An, Jeong Eun Park, Jieun Ka, Jongho Kim, Sarbjit S. Saini

Get full text

Diagnostic testing for chronic spontaneous urticaria with or without angioedema: The do's, don't and maybe's by Jonathan A. Bernstein, MD, Ignacio Ansotegui, MD, PhD, Riccardo Asero, MD, Aleena Banerji, MD, Stephen Betschel, HBSc, MD, Timothy Craig, DO, José Luis García-Abujeta, MD, René Maximiliano Gómez, MD, PhD, Anete S. Grumach, MD, PhD, Michihiro Hide, MD, PhD, David M. Lang, MD, Michael Levin, MD, PhD, Hilary J. Longhurst, PhD, Marcus Maurer, MD, Mario Morais-Almeida, MD, Dinh Nguyen Van, MD, PhD, Helena Pité, MD, PhD, Marc A. Riedl, MD, María Isabel Rojo Gutiérrez, MD, Sarbjit S. Saini, MD, Gordon Sussman, MD, Elias Toubi, MD, Andrea Zanichelli, MD, Bruce Zuraw, MD, Torsten Zuberbier, MD, PhD

Get full text